Luciferase therapeutic microcapsules for gene therapy

Artificial Cells, Blood Substitutes, and Biotechnology

Volumn 37, Issue 6, 2009, Pages 235-244

  Li, Anna Aihua ^a   Hou, Donna Y ^a   Shen, Feng ^a   Seidlitz, Eric P ^b   Potter, Murray A ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b HENDERSON GENERAL HOSPITAL   (Canada)

Author keywords

Alginate; CCCD camera; Gene therapy; Immuno isolation; Quantitative analysis

Indexed keywords

ALGINATE MICROCAPSULES; CELL VIABILITY; GENE THERAPY; IMMUNO-ISOLATION; IN-VITRO; LUCIFERASE EXPRESSION; MDCK CELLS; MICROCAPSULES; POLY-L-LYSINE; POST-IMPLANTATION; QUANTITATIVE ANALYSIS; UBIQUITIN;

ALGINATE; AMINO ACIDS; CAMERAS; GENE EXPRESSION; GENETIC ENGINEERING;

ENCAPSULATION;

ALGINATE POLYLYSINE ALGINATE; HYBRID PROTEIN; LUCIFERASE; RECOMBINANT ENZYME; UBIQUITIN; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOENGINEERING; CELL STRAIN; CELL VIABILITY; CONTROLLED STUDY; CYTOMEGALOVIRUS; ENCAPSULATION; ENZYME ACTIVITY; GENE THERAPY; IN VITRO STUDY; IN VIVO STUDY; MICROCAPSULE; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PROMOTER REGION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS;

ALGINATES; ANIMALS; CAPSULES; CELL LINE; CELL SURVIVAL; CELL TRANSPLANTATION; DOGS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GENETIC VECTORS; IMPLANTS, EXPERIMENTAL; LUCIFERASES; MICE; MICE, INBRED BALB C; PHARMACOKINETICS; POLYLYSINE;

CYTOMEGALOVIRUS;

EID: 70450227493     PISSN: 10731199     EISSN: 15324184     Source Type: Journal    
DOI: 10.3109/10731190903356537     Document Type: Article

References (48)

1. al-Hendy, A., Hortelano, G., Tannenbaum, G.S., Chang, P.L. (1995). Correction of the growth defect in dwarf mice with nonautologous microencapsulated myoblasts-an alternate approach to somatic gene therapy. Hum. Gene. Ther. 6:165-175.
2. Ross, C.J., Bastedo, L., Maier, S.A., Sands, M.S., Chang, P.L. (2000). Treatment of a lysosomal storage disease, mucopolysaccharidosis VII, with microencapsulated recombinant cells. Hum. Gene. Ther. 11:2117-2127.
3. Hortelano, G., Al-Hendy, A., Ofosu, F.A., Chang, P.L. (1996). Delivery of human factor IX in mice by encapsulated recombinant myoblasts: a novel approach towards allogeneic gene therapy of hemophilia B. Blood. 87:5095-5103.
4. Cirone, P., Bourgeois, J.M., Austin, R.C., Chang, P.L. (2002). A novel approach to tumor suppression with microencapsulated recombinant cells. Hum. Gene. Ther. 13:1157-1166.
5. Lohr, M., Hoffmeyer, A., Kroger, J., Freund, M., Hain, J., Holle, A., Karle, P., Knofel, W.T., Liebe, S., Muller, P., Nizze, H., Renner, M., Saller, R.M., Wagner, T., Hauenstein, K., Gunzburg, W.H., Salmons, B. (2001). Microencapsulated cell-mediated treatment of inoperable pancreatic carcinoma. Lancet. 357:1591-1592. (Pubitemid 32488821)
6. Shen, F., Poncet-Legrand, C., Somers, S., Slade, A., Yip, C., Duft, A.M., Winnik, F.M., Chang, P.L. (2003). Properties of a novel magnetized alginate for magnetic resonance imaging. Biotechnol. Bioeng. 83:282-292.
7. Barnett, B.P., Arepally, A., Karmarkar, P.V., Qian, D., Gilson, W.D., Walczak, P., Howland, V., Lawler, L., Lauzon, C., Stuber, M., Kraitchman, D.L., Bulte, J.W. (2007). Magnetic resonance-guided, real-time targeted delivery and imaging of magnetocapsules immunoprotecting pancreatic islet cells. Nat. Med. 13:986-991.
8. Ntziachristos, V., Yodh, A.G., Schnall, M., Chance, B. (2000). Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement. Proc. Natl. Acad. Sci. U.S.A. 97:2767-2772.
9. Hawrysz, D.J., Sevick-Muraca, E.M. (2000). Developments toward diagnostic breast cancer imaging using near-infrared optical measurements and fl uorescent contrast agents. Neoplasia. 2:388-417.
10. Tsien, R.Y. (1998). The green fluorescent protein. Annu. Rev. Biochem. 67: 509-544.
11. Heim, R., Tsien, R.Y. (1996). Engineering green fl uorescent protein for improved brightness, longer wavelengths and fl uorescence resonance energy transfer. Curr. Biol. 6:178-182.
12. Hastings, J.W. (1996). Chemistries and colors of bioluminescent reactions: a review. Gene. 173:5-11.
13. de Wet, J.R., Wood, K.V., DeLuca, M., Helinski, D.R., Subramani, S. (1987). Firefl y luciferase gene: structure and expression in mammalian cells. Mol. Cell. Biol. 7: 725-737.
14. Contag, C.H., Bachmann, M.H. (2002). Advances in in vivo bioluminescence imaging of gene expression. Annu. Rev. Biomed. Eng. 4:235-260.
15. Rehemtulla, A., Stegman, L.D., Cardozo, S.J., Gupta, S., Hall, D.E., Contag, C.H., Ross, B.D. (2000). Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. Neoplasia. 2:491-495.
16. Lu, P.H., Negrin, R.S. (1994). A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodefi ciency. J. Immunol. 153: 1687-1696.
17. Edinger, M., Sweeney, T.J., Tucker, A.A., Olomu, A.B., Negrin, R.S., Contag, C.H. (1999). Noninvasive assessment of tumor cell proliferation in animal models. Neoplasia. 1 303-310.
18. Sweeney, T.J., Mailander, V., Tucker, A.A., Olomu, A.B., Zhang, W., Cao, Y., Negrin, R.S., Contag, C.H. (1999). Visualizing the kinetics of tumor-cell clearance in living animals. Proc. Natl. Acad. Sci. U.S.A. 96:12044-12049.
19. Edinger, M., Cao, Y.A., Verneris, M.R., Bachmann, M.H., Contag, C.H., Negrin, R.S. (2003). Revealing lymphoma growth and the effi cacy of immune cell therapies using in vivo bioluminescence imaging. Blood. 101:640-648.
20. Schmidt, E.V., Christoph, G., Zeller, R., Leder, P. (1990). The cytomegalovirus enhancer: a pan-active control element in transgenic mice. Mol. Cell. Biol. 10:4406-4411.
21. Carmeliet, P., Jain, R.K. (2000). Angiogenesis in cancer and other diseases. Nature. 407:249-257.
22. Wang, Y., Wang, G., O'Kane, D.J., Szalay, A.A. (2001). A study of protein-protein interactions in living cells using luminescence resonance energy transfer (LRET) from Renilla luciferase to Aequorea GFP. Mol. Gen. Genet. 264:578-587.
23. Ray, P., Pimenta, H., Paulmurugan, R., Berger, F., Phelps, M.E., Iyer, M., Gambhir, S.S. (2002). Noninvasive quantitative imaging of protein-protein interactions in living subjects. Proc. Natl. Acad. Sci. U.S.A. 99: 3105-3110.
24. Cao, Y.A., Wagers, A.J., Beilhack, A., Dusich, J., Bachmann, M.H., Negrin, R.S., Weissman, I.L., Contag, C.H. (2004). Shifting foci of hematopoiesis during reconstitution from single stem cells. Proc. Natl. Acad. Sci. U.S.A. 101:221-226.
25. Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J. (1951). Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
26. Li, A.A., MacDonald, N.C., Chang, P.L. (2003). Effect of growth factors and extracellular matrix materials on the proliferation and differentiation of microencapsulated myoblasts. J. Biomater. Sci. Polym. Ed. 14:533-549.
27. Freshney, R. (1987). Culture of Animal Cells: A Manual of Basic Technique. Alan R. Liss Inc., New York, p.117.
28. Edinger, M., Cao, Y.A., Hornig, Y.S., Jenkins, D.E., Verneris, M.R., Bachmann, M.H., Negrin, R.S., Contag, C.H. (2002). Advancing animal models of neoplasia through in vivo bioluminescence imaging. Eur. J. Cancer. 38:2128-2136.
29. Rice, B.W., Cable, M.D., Nelson, M.B. (2001). In vivo imaging of light-emitting probes. J. Biomed. Opt. 6: 432-440.
30. Cirone, P., Shen, F., Chang, P.L. (2005). A multiprong approach to cancer gene therapy by coencapsulated cells. Cancer. Gene. Ther. 12:369-380.
31. Shen, F., Li, A.A., Cornelius, R.M., Cirone, P., Childs, R.F., Brash, J.L., Chang, P.L. (2005). Biological properties of photocrosslinked alginate microcapsules. J. Biomed. Mater. Res. B. Appl. Biomater. 75:425-434.
32. Krieg, A.M. (1999). Direct immunologic activities of CpG DNA and implications for gene therapy. J. Gene. Med. 1:56-63.
33. Krieg, A.M., Yi, A.K., Matson, S., Waldschmidt, T.J., Bishop, G.A., Teasdale, R., Koretzky, G.A., Klinman, D.M. (1995). CpG motifs in bacterial DNA trigger direct B-cell activation. Nature. 374:546-549.
34. Klinman, D.M., Yi, A.K., Beaucage, S.L., Conover, J., Krieg, A.M. (1996). CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. Proc. Natl. Acad. Sci. U.S.A. 93:2879-2883.
35. Sparwasser, T., Koch, E.S., Vabulas, R.M., Heeg, K., Lipford, G.B., Ellwart, J.W., Wagner, H. (1998). Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur. J. Immunol. 28:2045-2054.
36. Scheule, R.K., St George, J.A., Bagley, R.G., Marshall, J., Kaplan, J.M., Akita, G.Y., Wang, K.X., Lee, E.R., Harris, D.J., Jiang, C., Yew, N.S., Smith, A.E., Cheng, S.H. (1997). Basis of pulmonary toxicity associated with cationic lipidmediated gene transfer to the mammalian lung. Hum. Gene. Ther. 8:689-707.
37. Yew, N.S., Zhao, H., Wu, I.H., Song, A., Tousignant, J.D., Przybylska, M., Cheng, S.H. (2000). Reduced infl ammatory response to plasmid DNA vectors by elimination and inhibition of immunostimulatory CpG motifs. Mol. Ther. 1:255-262.
38. Yew, N.S., Zhao, H., Przybylska, M., Wu, I.H., Tousignant, J.D., Scheule, R.K., Cheng, S.H. (2002). CpG-depleted plasmid DNA vectors with enhanced safety and long-term gene expression in vivo. Mol. Ther. 5:731-738.
39. Zhao, H., Hemmi, H., Akira, S., Cheng, S.H., Scheule, R.K., Yew, N.S. (2004). Contribution of Toll-like receptor 9 signaling to the acute infl ammatory response to nonviral vectors. Mol. Ther. 9:241-248.
40. Hyde, S.C., Pringle, I.A., Abdullah, S., Lawton, A.E., Davies, L.A., Varathalingam, A., Nunez-Alonso, G., Green, A.M., Bazzani, R.P., Sumner-Jones, S.G., Chan, M., Li, H., Yew, N.S., Cheng, S.H., Boyd, A.C., Davies, J.C., Griesenbach, U., Porteous, D.J., Sheppard, D.N., Munkonge, F.M., Alton, E.W., Gill, D.R. (2008). CpGfree plasmids confer reduced infl ammation and sustained pulmonary gene expression. Nat. Biotechnol. 26:549-551.
41. Yew, N.S., Przybylska, M., Ziegler, R.J., Liu, D., Cheng, S.H. (2001). High and sustained transgene expression in vivo from plasmid vectors containing a hybrid ubiquitin promoter. Mol. Ther. 4:75-82.
42. Cheng, D., Lo, C., Sefton, M.V. (2008). Effect of mouse VEGF(164) on the viability of hydroxyethyl methacrylate-methyl methacrylate-microencapsulated cells in vivo: Bioluminescence imaging. J. Biomed. Mater. Res A. 87:321-331
43. Surzyn, M., Symes, J., Medin, J.A., Sefton, M.V. (2008). IL- 10 secretion increases signal persistence of HEMA-MMAmicroencapsulated luciferase-modifi ed CHO fi broblasts in mice. Tissue. Eng. Part A. 15:127-136
44. Loudovaris, T., Charlton, B., Hodgson, R.J., Mandel, T.E. (1992). Destruction of xenografts but not allografts within cell impermeable membranes. Transplant. Proc.24: 2291-2292.
45. Bunger, C.M., Gerlach, C., Freier, T., Schmitz, K.P., Pilz, M., Werner, C., Jonas, L., Schareck, W., Hopt, U.T., de Vos, P. (2003). Biocompatibility and surface structure of chemically modifi ed immunoisolating alginate-PLL capsules. J. Biomed. Mater. Res. A. 67:1219-1227.
46. Sauter, B., Albert, M.L., Francisco, L., Larsson, M., Somersan, S., Bhardwaj, N. (2000). Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 191:423-434.
47. Li, M., Carpio, D.F., Zheng, Y., Bruzzo, P., Singh, V., Ouaaz, F., Medzhitov, R.M., Beg, A.A. (2001). An essential role of the NF-kappa B/Toll-like receptor pathway in induction of infl ammatory and tissue-repair gene expression by necrotic cells. J. Immunol. 166:7128-7135.
48. Schneider, B.L., Schwenter, F., Pralong, W.F., Aebischer, P. (2003). Prevention of the initial host immuno-infl ammatory response determines the long-term survival of encapsulated myoblasts genetically engineered for erythropoietin delivery. Mol. Ther. 7:506-514.